Tramadol Use in Pediatric Surgery: Trends After the Food and Drug Administration Black-Box Warning

Stephanie Y Chen1, Shadassa Ourshalimian1, Eugene Kim2

  • 1Division of Pediatric Surgery, Children's Hospital Los Angeles, Los Angeles, California.

Insights

Despite a 2017 FDA black-box warning, perioperative tramadol use in children under 12 continues. Factors like sex, age, and comorbidities influence prescribing, necessitating interventions to reduce its use in pediatric surgery.

Area of Science:

  • Pediatric Surgery
  • Pharmacology
  • Public Health

Background:

  • The U.S. Food and Drug Administration (FDA) issued a black-box warning in 2017, contraindicating tramadol in children younger than 12 years.
  • Longitudinal trends and factors influencing perioperative tramadol use in pediatric surgical patients remained unclear following the warning.

Purpose of the Study:

  • To evaluate temporal trends in perioperative tramadol use in children after the FDA's 2017 black-box warning.
  • To identify patient and institutional factors associated with tramadol use in pediatric surgical patients.

Main Methods:

  • A retrospective, multi-institutional cohort study was conducted using the Pediatric Health Information System database.
  • Data included children aged 2-18 years who underwent one of ten common surgeries between January 2009 and February 2020.
  • Hierarchical multivariable logistic regression analysis was used to identify factors associated with tramadol use.

Main Results:

  • Of 477,153 children, 1.2% received tramadol. Post-warning, 16.1% of tramadol recipients were under 12 years old.
  • Tramadol use in children under 12 decreased from 1.87% in 2016 to 0.66% in 2019.
  • Factors increasing tramadol likelihood included female sex, age ≥12 years, Midwest location, and specific comorbidities (gastrointestinal, metabolic, transplant-related). Hispanic/Latino ethnicity and public insurance were associated with decreased use.

Conclusions:

  • Tramadol prescribing persists in children under 12 undergoing surgery, despite the FDA contraindication.
  • Patient demographics, comorbidities, and institutional factors significantly influence perioperative tramadol use.
  • Interventions are necessary to further reduce the use of tramadol in pediatric surgical patients.
Abstract

Related Concept Videos

Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
837
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
410
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.1K
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
683
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
190
Drug Regulation01:25

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.7K